Hopefully it's something of great significance for AR to be 4 months late past anticipated filing date of January 14th. Last year the company was quick to notify if something was going to be late, even though when things were finally filed, they were later than expected. This silent treatment is not normal for GNCP. jmo.
The same thing happened last year with the same hopes of getting back on track....as you can see it did anything but get back on track. The longer the OTC disclosures go absent the higher the probability they decided at some point to not renew the OTC disclosure subscription (which costs $4200 per year)...in which case it will go as silent as its "sisters".
News 
Market Data 
Discover 
